Investing Profile
Wende Hutton
Your Intro Paths to Wende Hutton
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Find Wende Hutton on
cbCurrent Investing Position
Canaan Partners General Partner
Investment Range
$250K - $20.0M
Sweet Spot
$10.0M
Investments On Record
56
Current Fund Size
$800M
Wende Hutton is on these Sector & Stage Rankings
Pharmaceuticals (Seed)Pharmaceuticals (Series A)Pharmaceuticals (Seed)Pharmaceuticals (Series A)BioTech (Series A)Health & Hospital Services (Series A)BioTech (Seed)Health IT (Series A)Health & Hospital Services (Seed)Health IT (Seed)BioTech (Series A)BioTech (Seed)Health & Hospital Services (Series A)Health IT (Series A)Health & Hospital Services (Seed)Health IT (Seed)Female InvestorsDiverse InvestorsSan Francisco Bay Area
Wende Hutton's Investments On Record (19)
Company | StageDateRound Size | Total Raised |
---|---|---|
OncoResponse | Series UnknownMay 2023$14M Series CMar 2021$41M Series BSep 2018$40M Series AMay 2016$13M | $110M |
Antiva Biosciences | Series EApr 2023$53M Series DNov 2021$31M Series CJul 2018$15M Series CMar 2017$22M Series BAug 2015$16M | $140M |
MoCaFi | Series AFeb 2021$12M | $40M |
Hyalex Orthopaedics | Series AMar 2019$17M Series AMay 2017$16M | $33M |
Glooko | Series CJun 2017$35M Series CSep 2016$8M Series BMar 2015$17M | $73M |
ReVision Optics | Series UnknownNov 2016$32M Series EJul 2013$55M Series EApr 2013$15M Series DJul 2010$35M Series CJun 2006$3M Series COct 2005$12M Series CDec 2004$5M | $180M |
Chrono Therapeutics | Series BSep 2016$48M Series AJun 2014$32M | $80M |
Minimally invasive devices | Series CNov 2015$14M Debt FinancingJun 2014$6M Series BJun 2013$3M Series BMar 2013$9M | $32M |
Investors who invest with Wende Hutton